Avant Diagnostics Inc Share Price
Equities
US05350M1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2021 | Avant Diagnostics : AvidXchange Shares Fall in Trading Debut | MT |
2021 | Avant Diagnostics : AvidXchange Prices IPO at $25 Per Share | MT |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/17/01 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 24/20/24 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 12/16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 25/18/25 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/17/01 |
Director/Board Member | 43 | - |
1st Jan change | Capi. | |
---|---|---|
-41.97% | 792.19Cr | |
+5.99% | 350.83Cr | |
-4.31% | 217.71Cr | |
-21.69% | 196.83Cr | |
-24.94% | 157.87Cr | |
+31.45% | 114.37Cr | |
+26.75% | 79Cr | |
-9.83% | 69Cr | |
-26.33% | 53Cr |
- Stock Market
- Equities
- Stock